戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 appropriate timing of phlebotomy and lung or heart-lung transplantation.
2              Three of five patients survived heart-lung transplantation.
3  considered so severe as to require combined heart-lung transplantation.
4  available to prevent RV failure, except for heart/lung transplantation.
5 and 31 December 1993, 157 patients underwent heart-lung transplantation; 126 survived at least six mo
6                   On multivariable analysis, heart-lung transplantation and double-lung transplantati
7                                         Both heart-lung transplantation and double-lung transplantati
8 ite the life-threatening nature of heart and heart-lung transplantation and the severity of illness,
9 ungs (n=7) from patients with PAH undergoing heart/lung transplantation and compared with tissue obta
10 s using RV tissue of PAH patients undergoing heart/lung transplantation and nonfailing donors.
11  nevertheless, both lung transplantation and heart-lung transplantation candidates in this era enjoye
12 ry in lung sections from patients undergoing heart-lung transplantation for PPH (n=11, including 3 fa
13  without ECMO (BLTx ventilation) or combined heart-lung transplantation for severe PH.
14 iving single lung, double lung, and combined heart-lung transplantation from 1984 to 1997 at the Univ
15 omosis is a recognized complication of adult heart-lung transplantation (HLT) and lung transplantatio
16  ventilation (MV) can be used as a bridge to heart-lung transplantation (HLT).
17                                              Heart-lung transplantation (HLTx) is an effective treatm
18 charts of patients undergoing either lung or heart-lung transplantation in a tertiary transplantation
19 linical outcomes for patients after combined heart-lung transplantation in the current era.
20       Patients with CF who underwent lung or heart-lung transplantation in the United States or Unite
21                                              Heart lung transplantation is a viable treatment option
22 ving PGD using the International Society for Heart & Lung Transplantation (ISHLT)-defined criteria.
23                 A rodent heterotopic working heart-lung transplantation model was used for studying a
24            We examined the effect of lung or heart-lung transplantation on the survival of a cohort o
25                                              Heart-lung transplantation or bilateral lung transplanta
26 ral communication, an expected finding after heart-lung transplantation or double-lung transplantatio
27 01), hospitalization for PAH, and/or lung or heart-lung transplantation (OR: 0.442; 95% CI: 0.309 to
28                     Lung transplantation and heart-lung transplantation represent surgical options fo
29                                           In heart-lung transplantation, the incidence of hemolysis f
30  been less dramatic in the field of lung and heart-lung transplantation, where there is little eviden